Ozempic maker Novo Nordisk confirmed Tuesday its popular weight loss drug Wegovy had been approved for sale in China, a key victory for the Danish firm that opens the door to an enormous market ...

of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular weight-loss drug Wegovy has been approved to start being sold in China. Ozempic, another drug with the ...

Novo Nordisk‘s hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world’s second-largest economy and the country estimated to hold the highest number of ...

China has approved Novo Nordisk A/S’s blockbuster Wegovy for chronic weight management, opening up competition for next-generation obesity drugs in the world’s second-largest economy.

Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Novo ( NVO ) launched Wegovy in the US in 2021.

Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk NOVO.B1.91%increase; green up pointing triangle to begin selling it in the world’s second ...

Novo Nordisk has gained approval to start marketing its blockbuster weight-loss drug Wegovy in China, opening the door for the Danish pharmaceutical giant to further boost sales of the medicine ...

The list price of Wegovy in the United States is about $1,349 for a month’s supply. The Novo spokesperson did not comment on the price in China. Novo gained approval for Wegovy in China in June ...

SHANGHAI, June 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and ...